Skip to main content
OpenTrials

Clinical trial condition

Influenza, Human

Explore clinical trials studying Influenza, Human. Study availability and eligibility vary by location and protocol.

188 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Influenza, Human trial results

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza

NCT05596734

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations
  • North Alabama Research Center Athens, Alabama, United States
  • The Heart Center Athens, Alabama, United States
  • HOPE Research Institute Phoenix, Arizona, United States
  • The Pain Center of Arizona Phoenix, Arizona, United States
View all 59 locations
View Trial Details
Completed

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

NCT05823974

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Hialeah, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Chicago, Illinois, United States
  • GSK Investigational Site Valparaiso, Indiana, United States
View all 41 locations
View Trial Details
Completed

A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older

NCT05540522

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • North Alabama Research Center Athens, Alabama, United States
  • St. Vincent's Birmingham Hospital Birmingham, Alabama, United States
  • Accel Research Sites Network - Birmingham Clinical Research Unit Birmingham, Alabama, United States
  • Ross Bridge Medical Practice, LLC-CCT Research Birmingham, Alabama, United States
View all 321 locations
View Trial Details
Completed

The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older

NCT06015282

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • Alliance for Multispecialty Research (AMR) Phoenix Tempe, Arizona, United States
  • Baptist Health Center for Clinical Research Little Rock, Arkansas, United States
  • Marvel Clinical Research Huntington Beach, California, United States
  • Paradigm Clinical Research Center, LLC Redding, California, United States
View all 96 locations
View Trial Details
Completed

A Study to Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Participants Aged 65 Years and Older in India

NCT05648357

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Belagavi, India
  • GSK Investigational Site Kattankulathur, India
  • GSK Investigational Site Nashik, India
  • GSK Investigational Site Nashik, India
View Trial Details
Completed

Efficacy Study With QIVc in Pediatric Subjects

NCT03932682

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • International Centre for Diarrhoeal Disease Research, Bangladesh Dhaka, Bangladesh
  • 10008-Medical Center Viva Feniks Dobrich, Bulgaria
  • 10007-MHAT Dr. Stamen Iliev AD Montana, Bulgaria
  • 10003-UMHAT Dr. Georgi Stranski EAD Pleven, Bulgaria
View all 74 locations
View Trial Details
Completed

Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine

NCT03927131

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • Centro de Pesquisa Clínica Universidade Federal do Ceará - UFC (Site FOR01) Fortaleza, Ceará, Brazil
  • Núcleo de Pesquisa e Desenvolvimento de Medicamentos - NPDM - Universidade Federal do Ceará - UFC (Site FOR 01) Fortaleza, Ceará, Brazil
  • Centro de Pesquisa e desenvolvimento de fármacos (Site BHZ01) Belo Horizonte, Minas Gerais, Brazil
  • Centro de Pesquisa Clínica Real Hospital Português de Beneficência em Pernambuco (Site REC01) Recife, Pernambuco, Brazil
View Trial Details
Completed

Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults

NCT05875961

Conditions
Infection Viral, Infections, Influenza, Human, +5 more
Locations
  • Meridian Clinical Research Rockville, Maryland, United States
  • Meridian Clinical Research Lincoln, Nebraska, United States
  • Meridian Clinical Research Omaha, Nebraska, United States
  • West Visayas State University Medical Center Iloilo City, Philippines
View Trial Details

Related conditions